These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33023825)

  • 1. Differences in breast cancer risk after benign breast disease by type of screening diagnosis.
    Louro J; Román M; Posso M; Comerma L; Vidal C; Saladié F; Alcantara R; Sanchez M; Quintana MJ; Del Riego J; Ferrer J; Peñalva L; Bargalló X; Prieto M; Sala M; Castells X
    Breast; 2020 Dec; 54():343-348. PubMed ID: 33023825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
    Castells X; Domingo L; Corominas JM; Torá-Rocamora I; Quintana MJ; Baré M; Vidal C; Natal C; Sánchez M; Saladié F; Ferrer J; Vernet M; Servitja S; Rodríguez-Arana A; Roman M; Espinàs JA; Sala M
    Breast Cancer Res Treat; 2015 Jan; 149(1):237-44. PubMed ID: 25503778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
    Posso M; Alcántara R; Vázquez I; Comerma L; Baré M; Louro J; Quintana MJ; Román M; Marcos-Gragera R; Vernet-Tomas M; Saladie F; Vidal C; Bargalló X; Peñalva L; Sala M; Castells X;
    Eur Radiol; 2022 Jan; 32(1):621-629. PubMed ID: 34156554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign breast disease, mammographic breast density, and the risk of breast cancer.
    Tice JA; O'Meara ES; Weaver DL; Vachon C; Ballard-Barbash R; Kerlikowske K
    J Natl Cancer Inst; 2013 Jul; 105(14):1043-9. PubMed ID: 23744877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
    Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
    PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study.
    Román M; Sala M; Baré M; Posso M; Vidal C; Louro J; Sánchez M; Peñalva L; Castells X;
    Breast; 2019 Aug; 46():108-115. PubMed ID: 31132476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography.
    Román M; Louro J; Posso M; Vidal C; Bargalló X; Vázquez I; Quintana MJ; Alcántara R; Saladié F; Del Riego J; Peñalva L; Sala M; Castells X; On Behalf Of The Bele And Iris Study Groups
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
    Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
    Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent vs Incident Screen: Why Does It Matter?
    Hayward JH; Lee AY; Sickles EA; Ray KM
    J Breast Imaging; 2024 May; 6(3):232-237. PubMed ID: 38190264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
    Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
    Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
    Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.
    Kam JK; Naidu P; Rose AK; Mann GB
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):400-6. PubMed ID: 23870334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.
    Sala M; Comas M; Macià F; Martinez J; Casamitjana M; Castells X
    Radiology; 2009 Jul; 252(1):31-9. PubMed ID: 19420316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from 10 years of breast screening in Wales.
    Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
    J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.